New partnership offers digital self-care to patients with long-term conditions
A new digital health collaboration, formed between My mHealth and LumiraDx Care Solutions, has the potential to support millions of patients in the UK to self-care under the guidance of their care teams.
The initiative will provide an integrated patient and clinician platform, allowing self-care for patients on anticoagulation therapy in addition to those living with COPD, asthma, diabetes and heart disease through a range of integrated, digital care programmes.
LumiraDx Care Solutions already supports over 2700 NHS locations across the UK and has partnered with My mHealth to provide clinical management software and digital technology to give as many patients as possible the knowledge, skills and confidence to take control of their condition, whilst reducing avoidable costs through digital transformation and education.
An initial result of the partnership is the engage patient app which is a new platform where patients can learn how to manage their condition whilst staying connected to their care team. The seamless two-way data flow between engage and the main clinical systems means that care teams have continual visibility of their patients’ progress.
Management of long-term conditions is one of the biggest challenges facing the NHS, taking up half of all GP appointments and accounting for around £7 in every £10 of total health and social care expenditure. This new model of supported self-care has the potential to make significant savings for the NHS.
- LumiraDx Care Solutions is the home of INRstar, the UK’s market-leading anticoagulation clinical decision support software (CDSS), and engage patient app, the patient app, which offers a range of self-care programmes for long-term conditions. engage was ‘Highly Commended’ in the Best Healthcare App category of the Building Better Healthcare Awards, November 2017. For more information visit: www.lumiradxcaresolutions.com
- My mHealth is the home of the innovative myCOPD app, which teaches patients with chronic obstructive pulmonary disease the correct techniques and skills to rehabilitate and improve their condition and is the only one of its kind to have been approved by the NHS. The range of self-care apps also includes asthma, diabetes and heart disease. For more information visit: https://mymhealth.com/